Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
24,482,713
-
Share change
-
+883,676
-
Total reported value
-
$1,502,054,443
-
Put/Call ratio
-
228%
-
Price per share
-
$61.35
-
Number of holders
-
119
-
Value change
-
+$81,527,891
-
Number of buys
-
68
-
Number of sells
-
50
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2014
As of 30 Sep 2014 AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) had 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,482,713 shares of stock of the company.
Largest 10 holders included FMR LLC, Third Rock Ventures, LLC, Flagship Ventures 2007 General Partner LLC, BB Biotech AG, WELLINGTON MANAGEMENT CO LLP, LORD, ABBETT & CO. LLC, Capital World Investors, VANGUARD GROUP INC, BlackRock Fund Advisors, and State Street Corp.
This table shows 119 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.